[Federal Register Volume 87, Number 226 (Friday, November 25, 2022)]
[Notices]
[Page 72510]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25686]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation Nos. 701-TA-558 and 731-TA-1316 (Review)]


1-Hydroxyethylidene-1, 1-Diphosphonic Acid (HEDP) From China

Determination

    On the basis of the record \1\ developed in the subject five-year 
reviews, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the countervailing and antidumping duty 
orders on 1-hydroxyethylidene-1, 1-diphosphonic acid from China would 
be likely to lead to continuation or recurrence of material injury to 
an industry in the United States within a reasonably foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in Sec.  207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission instituted these reviews on April 1, 2022 (87 FR 
19125) and determined on July 5, 2022 that it would conduct expedited 
reviews (87 FR 64248, October 24, 2022).
    The Commission made these determinations pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). It completed and filed its 
determinations in these reviews on November 18, 2022. The views of the 
Commission are contained in USITC Publication 5386 (November 2022), 
entitled 1-Hydroxyethylidene-1, 1-Diphosphonic Acid (HEDP) from China: 
Investigation Nos. 701-TA-558 and 731-TA-1316 (Review).

    By order of the Commission.
    Issued: November 18, 2022.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2022-25686 Filed 11-23-22; 8:45 am]
BILLING CODE 7020-02-P